CareRx (TSX:CRRX) General and Admin. Expense: C$33.7 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSX:CRRX CareRx Corp TSX:CRRX
66 GF Score
Price C$3.37
GF Value C$2.28
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is CareRx General and Admin. Expense?

CareRx TSX:CRRX +0.60% 66 General and Admin. Expense is C$33.7 Mil as of Jun. 2026. GuruFocus rates TSX:CRRX with a GF Score™ of 66/100 and a GF Value™ of C$2.28 (Significantly Overvalued). The stock has 3 warning signs investors should review.

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. CareRx's General and Admin. Expense for the three months ended in Jun. 2026 was C$8.0 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Jun. 2026 was C$33.7 Mil.

CareRx General and Admin. Expense Related Terms

CareRx General and Admin. Expense Historical Data

* Premium members only.

The historical data trend for CareRx's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CareRx General and Admin. Expense Chart

CareRx Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
General and Admin. Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25.13 34.43 30.66 32.75 34.23

CareRx Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
General and Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.15 8.04 9.68 8.04 7.96
TSX:CRRX
66GF Score
CareRx Corp TSX:CRRX
General and Admin. Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CareRx General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was C$33.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a General and Admin. Expense of C$33.7 Mil mean?
CareRx (TSX:CRRX) has a General and Admin. Expense of C$33.7 Mil as of Jun. 2026. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on CareRx and its competitors.
Is CareRx's General and Admin. Expense too high?
CareRx's current General and Admin. Expense is C$33.7 Mil. Overall, CareRx has a GF Score™ of 66/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does CareRx's General and Admin. Expense compare to HCA and THC?
CareRx's General and Admin. Expense of C$33.7 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good General and Admin. Expense for a Healthcare Providers & Services company?
A good General and Admin. Expense depends on the Healthcare Providers & Services industry context. However, General and Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high General and Admin. Expense mean?
A high General and Admin. Expense can signal that a stock is expensive relative to its fundamentals. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on CareRx and its competitors. CareRx's current General and Admin. Expense is C$33.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CareRx stock overvalued right now?
Based on GuruFocus' analysis, CareRx (TSX:CRRX) is currently considered Significantly Overvalued. The stock's GF Value™ is C$2.28, compared to a current price of C$3.37 — trading 47.8% above its estimated fair value. The current General and Admin. Expense is C$33.7 Mil. CareRx's overall GF Score™ is 66/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is General and Admin. Expense calculated?
General and Admin. Expense is calculated from a company's financial statements. For CareRx (TSX:CRRX), the current General and Admin. Expense is C$33.7 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CareRx (TSX:CRRX) Overvalued in 2026?

Based on GuruFocus' analysis, CareRx stock appears to be overvalued. The current stock price of C$3.37 is trading 47.8% above its estimated GF Value™ of C$2.28. GuruFocus considers CareRx to be Significantly Overvalued.

Key valuation signals for TSX:CRRX:

  • General and Admin. Expense: C$33.7 Mil
  • GF Value™: C$2.28 vs. price of C$3.37 (47.8% above fair value)
  • GF Score™: 66/100 with 3 warning signs

No single metric tells the full story. See the TSX:CRRX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CareRx Business Description

Other Exchanges CHHHF:USA
Address 320 Bay Street, Suite 1200, Toronto, ON, CAN, M5H 4A6
CareRx Corp is a provider of specialty pharmacy services to seniors. The company is a national organization with a large network of pharmacy fulfilment centers strategically located across the country. This allows it to deliver medications in a timely and cost-effective manner and quickly respond to routine changes in medication management. It takes an active role in working with its home operator partners to promote resident health, staff education and medication system quality and efficiency. The Company has one reportable segment which consists of the Company-owned and operated institutional pharmacy business. Geographically it derives revenue from the sales of goods and capitated service fees in Ontario and Western Canada.
66GF Score

Get the complete analysis for TSX:CRRX

General and Admin. Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$3.37
Price
C$2.28
GF Value